环保局在改变对甘硫酸盐警告的立场之前与Bayer进行了会晤,引发了对透明度的关切。 EPA met with Bayer before shifting stance on glyphosate warnings, sparking transparency concerns.

美国环保局内部记录显示,在2025年6月,环保局署长Lee Zeldin会见了Bayer CEO Bill Anderson和行政人员,讨论最高法院关于甘磷酸酯的诉讼,恰好在特朗普政府改变其法律立场支持Bayer关于联邦标注规则优先于州警示的说法之前。 Internal EPA records reveal that in June 2025, EPA Administrator Lee Zeldin met with Bayer CEO Bill Anderson and executives to discuss Supreme Court litigation over glyphosate, just before the Trump administration shifted its legal stance to support Bayer’s claim that federal labeling rules preempt state warnings. 会议召开时Bayer正面临数千起癌症诉讼, 环保局后来撤销了2022年一封确认加利福尼亚有权要求癌症警告的信件。 The meeting occurred as Bayer faced thousands of cancer lawsuits, and the EPA later removed a 2022 letter acknowledging California’s right to require cancer warnings. 2025年12月,司法部向最高法院提交了一份支持Bayer立场的案情摘要,推翻了司法部先前的意见,引起了对监管影响和透明度的关切。 In December 2025, the Justice Department filed a Supreme Court brief backing Bayer’s position, a reversal from prior DOJ views, raising concerns about regulatory influence and transparency. 环境倡导者批评环保局与Bayer之间的密切联系,质疑联邦决定的独立性。 Environmental advocates criticized the close ties between the EPA and Bayer, questioning the independence of federal decisions.